Abdominelle Weichgewebstumoren

[1]  R. DeMatteo,et al.  The GIST of Advances in Treatment of Advanced Gastrointestinal Stromal Tumor. , 2022, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[2]  M. von Mehren,et al.  Gastrointestinal Stromal Tumors: What Is the Best Sequence of TKIs? , 2022, Current Treatment Options in Oncology.

[3]  P. Argani,et al.  A review of neoplasms with MITF/MiT family translocations. , 2022, Histology and histopathology.

[4]  C. Serrano,et al.  New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors , 2022, Current Oncology Reports.

[5]  A. Ardizzoni,et al.  SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor , 2022, Frontiers in Oncology.

[6]  S. Sleijfer,et al.  Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  I. Brčić,et al.  Update on Molecular Genetics of Gastrointestinal Stromal Tumors , 2021, Diagnostics.

[8]  F. Puglisi,et al.  A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity , 2020, Journal of personalized medicine.

[9]  C. Raut,et al.  Desmoid tumors: To treat or not to treat, That is the question , 2020, Cancer.

[10]  K. Thway,et al.  Soft Tissue Special Issue: Perivascular and Vascular Tumors of the Head and Neck , 2020, Head and Neck Pathology.

[11]  Narasimhan P. Agaram,et al.  GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions , 2019, Modern Pathology.

[12]  A. Agaimy.  SWI/SNF Complex-Deficient Soft Tissue Neoplasms: A Pattern-Based Approach to Diagnosis and Differential Diagnosis. , 2019, Surgical pathology clinics.

[13]  Asha A. Nair,et al.  Gastroblastoma harbors a recurrent somatic MALAT1–GLI1 fusion gene , 2017, Modern Pathology.

[14]  H. Gevensleben,et al.  Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events. , 2017, Human pathology.

[15]  R. Ricci.  Syndromic gastrointestinal stromal tumors , 2016, Hereditary Cancer in Clinical Practice.

[16]  C. Antonescu,et al.  Recurrent MALAT1–GLI1 oncogenic fusion and GLI1 up‐regulation define a subset of plexiform fibromyxoma , 2016, The Journal of pathology.

[17]  E. Wardelmann,et al.  Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy , 2015, Expert review of anticancer therapy.

[18]  A. D. Dei Tos,et al.  Myogenic Differentiation and Histologic Grading Are Major Prognostic Determinants in Retroperitoneal Liposarcoma , 2015, The American journal of surgical pathology.

[19]  S. Wiemann,et al.  Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad. , 2014, Endocrine-related cancer.

[20]  E. Wardelmann,et al.  β‐Catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid‐type fibromatosis , 2013, Histopathology.

[21]  D. Goltz,et al.  Activating PDGFRA mutations in inflammatory fibroid polyps occur in exons 12, 14 and 18 and are associated with tumour localization , 2012, Histopathology.

[22]  H. Järvinen,et al.  Family History, Surgery, and APC Mutation Are Risk Factors for Desmoid Tumors in Familial Adenomatous Polyposis: An International Cohort Study , 2011, Diseases of the colon and rectum.

[23]  A. Marx,et al.  MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. , 2010, The American journal of pathology.

[24]  L. Sobin,et al.  Plexiform Fibromyxoma: A Distinctive Benign Gastric Antral Neoplasm Not to be Confused With a Myxoid GIST , 2009, The American journal of surgical pathology.

[25]  L. Sobin,et al.  A Distinctive Novel Epitheliomesenchymal Biphasic Tumor of the Stomach in Young Adults (“Gastroblastoma”): A Series of 3 Cases , 2009, The American journal of surgical pathology.

[26]  E. Wardelmann,et al.  Inflammatory fibroid polyps harbour mutations in the platelet‐derived growth factor receptor alpha (PDGFRA) gene , 2008, The Journal of pathology.

[27]  J. Ellison,et al.  Clinical and molecular genetics of patients with the Carney–Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD , 2008, European Journal of Human Genetics.

[28]  J. Lasota,et al.  Gastrointestinal stromal tumors: pathology and prognosis at different sites. , 2006, Seminars in diagnostic pathology.

[29]  E. Wardelmann,et al.  PDGFRα‐ and c‐kit‐mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features , 2005 .

[30]  F. Collin,et al.  Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity , 2004, The Journal of pathology.

[31]  J. Fletcher,et al.  Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). , 2004, The American journal of pathology.

[32]  E. Wardelmann,et al.  Deletion of Trp‐557 and Lys‐558 in the juxtamembrane domain of the c‐kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors , 2003, International journal of cancer.